Literature DB >> 23637039

Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine.

Yongzhen Xiong1, Shengli Chen, Linhua Liu, Yi Zhao, Weiyan Lin, Jindong Ni.   

Abstract

We compared the serum levels of microRNA-155 (miR-155) between subjects with normal response to hepatitis B vaccine and nonresponders. Results showed that serum expression of miR-155 was significantly higher in nonresponders than in responders (6.40 versus 2.55; Z = 2.125, P = 0.034), suggesting that overexpression of miR-155 is correlated with nonresponsiveness to hepatitis B vaccine.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23637039      PMCID： PMC3697454          DOI： 10.1128/CVI.00044-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  10 in total

Review 1.  Fine-tuning of the innate immune response by microRNAs.

Authors:  Michael P Gantier; Anthony J Sadler; Bryan R G Williams
Journal:  Immunol Cell Biol       Date:  2007-07-10       Impact factor: 5.126

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

Review 3.  Real-time PCR quantification of precursor and mature microRNA.

Authors:  Thomas D Schmittgen; Eun Joo Lee; Jinmai Jiang; Anasuya Sarkar; Liuqing Yang; Terry S Elton; Caifu Chen
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

4.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells.

Authors:  Maurizio Ceppi; Patricia M Pereira; Isabelle Dunand-Sauthier; Emmanuèle Barras; Walter Reith; Manuel A Santos; Philippe Pierre
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-04       Impact factor: 11.205

5.  Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells.

Authors:  Emily Charrier; Paulo Cordeiro; Martine Cordeau; R'Kia Dardari; Annie Michaud; Michaël Harnois; Natacha Merindol; Sabine Herblot; Michel Duval
Journal:  Cell Immunol       Date:  2012-04-27       Impact factor: 4.868

6.  Hepatitis B vaccination strategy in vaccine low and non-responders: a matter of quantity of quality?

Authors:  Anna H Roukens; Leo G Visser
Journal:  Hum Vaccin       Date:  2011-06-01

7.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

9.  In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination.

Authors:  Chih-Ping Mao; Liangmei He; Ya-Chea Tsai; Shiwen Peng; Tae Heung Kang; Xiaowu Pang; Archana Monie; Chien-Fu Hung; T-C Wu
Journal:  Cell Biosci       Date:  2011-01-18       Impact factor: 7.133

10.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein.

Authors:  Li-Fan Lu; To-Ha Thai; Dinis Pedro Calado; Ashutosh Chaudhry; Masato Kubo; Kentaro Tanaka; Gabriel B Loeb; Hana Lee; Akihiko Yoshimura; Klaus Rajewsky; Alexander Y Rudensky
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745
  10 in total
  6 in total

1.  A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Authors:  Brenna C Simons; Philip R Spradling; Dana J T Bruden; Carolyn Zanis; Samantha Case; Tammy L Choromanski; Minjun Apodaca; Hazel D Brogdon; Gaelen Dwyer; Mary Snowball; Susan Negus; Michael G Bruce; Chihiro Morishima; Cindy Knall; Brian J McMahon
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

Review 2.  MicroRNA mediated regulation of immunity against gram-negative bacteria.

Authors:  Jonathon Keck; Rishein Gupta; Lane K Christenson; Bernard P Arulanandam
Journal:  Int Rev Immunol       Date:  2017-08-11       Impact factor: 5.311

3.  The Differential Expression and Possible Function of Long Noncoding RNAs in Liver Cells Infected by Dengue Virus.

Authors:  Xiao-Jun Wang; Shi-Chen Jiang; Hai-Xia Wei; Sheng-Qun Deng; Cheng He; Hong-Juan Peng
Journal:  Am J Trop Med Hyg       Date:  2017-09-28       Impact factor: 2.345

4.  The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies.

Authors:  Ruth Elizabeth Drury; Andrew John Pollard; Daniel O'Connor
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

5.  Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.

Authors:  Manal Al-Khanbashi; Stefano Caramuta; Adil M Alajmi; Ibrahim Al-Haddabi; Marwa Al-Riyami; Weng-Onn Lui; Mansour S Al-Moundhri
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

6.  Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Whitney L Simon; Krista M Goergen; Diane E Grill; Inna G Ovsyannikova; Gregory A Poland
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.